Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 594.78M | 598.05M | 587.67M | 591.19M | 571.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 594.78M | 598.05M | 587.67M | 591.19M | 571.41M |
| Cost of Revenue | 334.05M | 344.61M | 337.56M | 326.93M | 321.54M |
| Gross Profit | 260.73M | 253.44M | 250.11M | 264.25M | 249.88M |
| SG&A Expenses | 196.16M | 202.70M | 198.34M | 195.75M | 193.32M |
| Depreciation & Amortization | 4.45M | 4.57M | 4.77M | 4.39M | 4.27M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 534.65M | 551.88M | 540.67M | 527.07M | 519.13M |
| Operating Income | 60.13M | 46.17M | 47.00M | 64.12M | 52.29M |
| Income Before Tax | 91.21M | -19.23M | 28.99M | 49.23M | 27.23M |
| Income Tax Expenses | 29.38M | 6.29M | 12.47M | 16.66M | 12.63M |
| Earnings from Continuing Operations | 61.82M | -25.52M | 16.51M | 32.57M | 14.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -809.00K | 5.14M | 397.00K | -272.00K | -194.00K |
| Net Income | 61.01M | -20.38M | 16.91M | 32.30M | 14.40M |
| EBIT | 60.13M | 46.17M | 47.00M | 64.12M | 52.29M |
| EBITDA | 66.92M | 52.88M | 53.83M | 70.47M | 58.42M |
| EPS Basic | 1.86 | -0.62 | 0.52 | 0.99 | 0.44 |
| Normalized Basic EPS | 1.12 | 1.05 | 0.88 | 1.16 | 0.91 |
| EPS Diluted | 1.84 | -0.62 | 0.51 | 0.98 | 0.44 |
| Normalized Diluted EPS | 1.10 | 1.05 | 0.87 | 1.15 | 0.90 |
| Average Basic Shares Outstanding | 32.79M | 32.75M | 32.75M | 32.71M | 32.67M |
| Average Diluted Shares Outstanding | 33.22M | 32.75M | 33.14M | 33.05M | 32.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |